A stimulating new target for cancer immunotherapy

Lancet. 1999 Oct 9;354(9186):1225-7. doi: 10.1016/S0140-6736(99)90130-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • CD40 Antigens / therapeutic use*
  • Humans
  • Immunotherapy
  • Mice
  • Neoplasms, Experimental / therapy*
  • T-Lymphocytes / immunology

Substances

  • CD40 Antigens